SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors monitor escalating geopolitical tensions and erratic communications regarding military actions in the Middle East. The community remains deeply divided, with intense debates focusing on the potential for market volatility, the impact of rising oil prices, and the president's controversial social media activity.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors digest comments from Warren Buffett, who expressed regret over selling shares too early while noting that current valuations limit his appetite for further accumulation. Meanwhile, the stock faces downward pressure from ongoing geopolitical tensions in the Middle East and mixed technical signals as the market debates its growth prospects in the AI-driven landscape.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 ETF is experiencing extreme volatility as traders weigh conflicting headlines regarding a potential 45-day ceasefire with Iran against aggressive threats of military escalation. The community remains deeply divided, with intense debate over the reliability of these headlines, concerns about potential market manipulation, and speculation on how geopolitical instability will impact oil prices and long-term economic stability.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is trending due to significant community interest in its low circulating supply and the belief that the NFT sector is poised for a resurgence. Investors are actively discussing the potential for rapid price appreciation, frequently comparing the token's scarcity to major assets and debating the impact of future volume and potential exchange listings.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy Co. is surging following its recent Nasdaq debut and a new strategic drilling agreement, drawing significant attention from investors betting on its massive Arctic oil exploration potential. The community is sharply divided, with bulls highlighting the company's multi-billion barrel resource estimates and high-profile leadership, while skeptics warn of extreme volatility and the risks associated with speculative frontier drilling.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Gold is trending as investors weigh record quarterly earnings, a significant dividend increase, and the strategic move to IPO its North American assets against broader market volatility in the precious metals sector. The community is actively debating the company's growth potential amid surging gold prices and the long-term outlook for its mining operations, despite some disappointment over recent stock price performance relative to gold spot gains.

BioLLM

BioLLM is capturing market attention as the community anticipates the launch of its neuron-integrated AI language model on the app store. Enthusiasts are actively tracking development updates while debating the project's long-term potential versus concerns regarding its nature as a speculative asset.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors rally around the company's upcoming May 31 PDUFA date for its ADHD treatment, CTx-1301, while closely monitoring expectations for an imminent U.S. patent approval. The community is actively discussing the stock's potential as a multi-bagger, balancing optimism regarding the drug's clinical efficacy and patent strength against concerns about manufacturing-related information requests from the FDA and the potential for capital raises.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is currently at the center of a heated debate regarding AI-driven market valuations, with many investors debating whether the sector remains a primary growth engine or is an overextended bubble due for a correction. Market participants are intensely focused on upcoming earnings reports as a key catalyst to determine if the semiconductor rally has sufficient fundamental backing or if the sector is vulnerable to a broader mean-reversion.

Fidelity Covington Trust - Fidelity MSCI Communication Services Index ETF

Fidelity MSCI Communication Services Index ETF

FCOM is gaining attention as investors debate its role in capturing long-term growth across the evolving communications and digital media landscape. The community is actively discussing the sector's integration with AI and behavioral programming, while evaluating its performance alongside other communication ETFs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanda Pharmaceuticals (NASDAQ:VNDA) Share Price Passes Above 200-Day Moving Average   - Here's Why

Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Pass Above 200 Day Moving Average - Here's Why...

Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods

Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from...

Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Gap Up - Time to Buy?

Vanda Pharmaceuticals (NASDAQ:VNDA) Shares Gap Up - Here's Why...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Sees Significant Growth in Short Interest

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) was the recipient of a large increase in short interest in February. As of February 27th, there was short interest totaling 4,346,005...

Vanda Pharmaceuticals (NASDAQ:VNDA) Sets New 52-Week High - What's Next?

Vanda Pharmaceuticals (NASDAQ:VNDA) Sets New 12-Month High - What's Next...

Vanda Pharmaceuticals (NASDAQ:VNDA) Trading Up 8.1% - Should You Buy?

Vanda Pharmaceuticals (NASDAQ:VNDA) Trading Up 8.1% - Still a Buy...

Truist Financial Begins Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)

Truist Financial initiated coverage on Vanda Pharmaceuticals in a report on Thursday. They set a "buy" rating and a $18.00 price target on the stock...

Vanda Pharmaceuticals (NASDAQ:VNDA) CMO Joakim Wijkstrom Sells 30,800 Shares

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) CMO Joakim Wijkstrom sold 30,800 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...

Gunther Birznieks Sells 42,431 Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) Stock

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) SVP Gunther Birznieks sold 42,431 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of...

Insider Selling: Vanda Pharmaceuticals (NASDAQ:VNDA) SVP Sells 42,434 Shares of Stock

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) SVP Timothy Williams sold 42,434 shares of the business's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

VNDA
Vanda Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VNDA News

VNDAVanda Pharmaceuticals Inc